US Dollar vs MXN

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

ARTL Artelo Biosciences Inc

1.37

0.05 (3.79%)

31 May 2024 - Cerrado

Retrasado por 15 minutos

Form DEL AM - Delaying amendment

null

Artelo Biosciences (NASDAQ:ARTL)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Artelo Biosciences.

Artelo Biosciences (NASDAQ:ARTL)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Artelo Biosciences.

Noticias sobre Artelo Biosciences Inc ARTL

Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24
Miércoles 29 de Mayo 2024 (4 días hace) • GlobeNewswire Inc.

Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
Lunes 13 de Mayo 2024 (3 semanas hace) • GlobeNewswire Inc.

Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
Viernes 10 de Mayo 2024 (3 semanas hace) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy
Martes 23 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time
Lunes 22 de Abril 2024 (1 mes hace) • GlobeNewswire Inc.

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update
Lunes 25 de Marzo 2024 (2 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge
Martes 12 de Marzo 2024 (3 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy
Martes 23 de Enero 2024 (4 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12
Lunes 8 de Enero 2024 (5 meses hace) • GlobeNewswire Inc.

Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Martes 5 de Diciembre 2023 (6 meses hace) • GlobeNewswire Inc.

Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany
Jueves 30 de Noviembre 2023 (6 meses hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lunes 13 de Noviembre 2023 (7 meses hace) • Edgar (US Regulatory)

Más de Artelo Biosciences Inc Artículos de Noticias

Viel et Compagnie

Aldoro Resources

Collective Audience

AusNet Services Holdings...

Savers Value Village

Century Communities

Deutsche Telekom

Alderan Resources

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones